Startup India Government of India
Acculi Labs Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹15.75 Lakh
▲ 29% YoY
Net loss · FY 2022
₹46.44 Lakh
Net margin -294.8%
EBITDA · FY 2022
-₹41.59 Lakh
EBITDA margin -264%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.36 Lakh
Issued & subscribed
Open charges
₹22 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
About Acculi Labs Private Limited
Data last updated:
Acculi Labs Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 30 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U72900KA2017PTC103431. Its GSTIN is 29AAPCA6376B1ZE (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.36 Lakh. It is led by directors including Rupam Das and Akbar.
Its last annual general meeting (AGM) was held on 13 February 2023, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2022, the company reported a revenue of ₹15.75 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹46.44 Lakh (net margin -294.8%) and EBITDA of -₹41.59 Lakh (EBITDA margin -264%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.
The company is associated with 2 brands: Acculi and Lyfas. As per MCA filings, the company has open charges of ₹22 Lakh on record. The company has 14 deals on record (11 funding rounds, 3 secondary share transfers), with disclosed funding of ₹14.65 Cr; the latest was in August 2024. Its 10 peer companies in the Healthcare industry (Diagnostics and Pathology Labs) are compared by revenue, 5 larger and 5 smaller; the largest is Neuberg Anand Reference Laboratory Private Limited with revenue of ₹16.25 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acculi.com.
Company Details of Acculi Labs Private Limited
CIN U72900KA2017PTC103431
Registration Number 103431
Incorporation Date 30 May 2017
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 13 February 2023
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Rupam Das Director Akbar Director Moumita Das Director Recognitions & Rankings of Acculi Labs
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNo.31 Ground Floor 3rd Cross Basappa Layout Behind L.G.Godown Pattanagere Rajarajeshwari N, Agar, Bangalore, Karnataka, India – 560098
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
Comprehensive company report
Acculi Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Acculi Labs Private Limited
Acculi Labs operates two associated brands: Acculi and Lyfas. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of AI-based predictive and preventive digital health test and home remedy | lyfas.com | |
| Limited information available | acculi.com |
Business Activity of Acculi Labs Private Limited
The main business activity of Acculi Labs is professional, scientific and technical. In detail, this covers architecture, engineering activities, technical testing and analysis activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Acculi Labs Private Limited FY 2022 filings available
Acculi Labs Private Limited reported revenue of ₹15.75 Lakh (up 29% YoY) for FY 2022.
Revenue · FY 2022
₹15.75 Lakh ▲ 29%
Net loss · FY 2022
₹46.44 Lakh margin -294.8%
EBITDA · FY 2022
-₹41.59 Lakh margin -264%
Compounded Annual Growth Rate (CAGR) of Acculi Labs Private Limited
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 64%
3 years · compounded
▼ 29%
Revenue has grown at a compounded annual rate (CAGR) of 13% over three years, including 29% growth in the latest year. EBITDA rose 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Acculi Labs Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹15.75 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹41.59 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹46.44 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Acculi Labs Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -264% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -294.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acculi Labs are in the company report.
Premium access
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Acculi Labs Private Limited
Acculi Labs has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupam Das Also directs: Paio Investment Consultancy Private Limited | Director | 30 May 2017 | 9 Years 4 Months | Current |
| Akbar | Director | 26 Sep 2020 | 6 Years 0 Months | Current |
| Moumita Das Also directs: Subhankar Sports Private Limited | Director | 30 May 2017 | 9 Years 4 Months | Current |
Peer Comparison of Acculi Labs Private Limited
Acculi Labs Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neuberg Anand Reference Laboratory Private Limited | ₹16.25 Lakh (FY 2025) | •••• | •••• | -83.0% | •••• | Chennai, Tamil Nadu, India |
| Nextgen Lifecare Private Limited | ₹16.15 Lakh (FY 2025) | •••• | •••• | 685.0% | •••• | Lucknow, Uttar Pradesh, India |
| Varrow Health Private Limited | ₹16.08 Lakh (FY 2024) | •••• | •••• | 100.0% | •••• | Raipur, Chhattisgarh, India |
| Circee Health Private Limited | ₹16.08 Lakh (FY 2024) | •••• | •••• | 1557.0% | •••• | Mumbai, Maharashtra, India |
| Lifequest Diagnostic Centre Private Limited | ₹15.84 Lakh (FY 2025) | •••• | •••• | -25.0% | •••• | Modinagar, Uttar Pradesh, India |
| Acculi Labs Private Limited this company | ₹15.75 Lakh (FY 2022) | •••• | •••• | 29.0% | •••• | Bangalore, Karnataka, India |
| Vida Diagnostics Private Limited | ₹15.61 Lakh (FY 2024) | •••• | •••• | -72.0% | •••• | Kolkata, West Bengal, India |
| Omix Research and Diagnostics Laboratories Private Limited | ₹15.57 Lakh (FY 2025) | •••• | •••• | -81.0% | •••• | Bangalore, Karnataka, India |
| Daily Diagnostic Private Limited | ₹15.56 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| PGRS New Life Pharma Private Limited | ₹15.52 Lakh (FY 2021) | •••• | •••• | -58.0% | •••• | Badli, Haryana, India |
| Triveni Clinic Pvt Ltd | ₹15.49 Lakh (FY 2015) | •••• | •••• | -9.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Acculi Labs by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Acculi Labs Private Limited
Acculi Labs Private Limited is audited by AVINASH N & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AVINASH N & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Acculi Labs Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Acculi Labs Private Limited
Open charges
₹22 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2021 | Others | ₹22 Lakh | Open |
Total charge records: 1 View all charges
Deals & Funding of Acculi Labs Private Limited
Acculi Labs Private Limited has 14 deals on record (11 funding rounds, 3 secondary share transfers), with disclosed funding of ₹14.65 Cr; the latest was in August 2024.
Total deals
14
Funding rounds
11
Secondary share transfers
3
Disclosed funding
₹14.65 Cr
Deals on record (5 of 14)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2024 | Funding round · Seed | ₹12.55 Cr | Investors: Sabi Holding India Limited |
| Oct 2022 | Funding round | ₹4.9 Lakh | Investors: Startup Incubation and Innovation Centre- IIT Kanpur |
| May 2022 | Funding round | ₹8.2 Lakh | Investors: 3 individuals |
| May 2022 | Funding round | ₹18 Lakh | Investors: an individual |
| Apr 2022 | Funding round | ₹4.3 Lakh | Investors: 4 individuals |
Premium access
Full deal history
All 14 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Acculi Labs Private Limited
Acculi Labs Private Limited has a workforce of 0 employees as of Mar 29, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Acculi Labs Private Limited
Acculi Labs Private Limited has 13 board changes on record since 2017: 8 appointments and 5 cessations. The latest: Amit Mogra ceased to be Additional Director on 29 Jul 2022.
AGM
Acculi Labs Private Limited last Annual general meeting of members was held on 13 Feb 2023 as per latest MCA records.
Ceased
Amit Mogra ceased to be Additional Director.
Appointed
Amit Mogra was appointed as Additional Director.
Filing
Acculi Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
Ceased
Manjula Jeevanna ceased to be Additional Director.
Ceased
Helavarahundi Mahadevappa Geetha ceased to be Nominee Director.
Appointed
Manjula Jeevanna was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 22.00 Lakh with Charge ID 100411599 was registered on 08 Feb 2021.
Appointed
Helavarahundi Mahadevappa Geetha was appointed as Nominee Director.
Appointed
Akbar was appointed as Director.
Ceased
Hari Prasath ceased to be Director.
Ceased
Praveen Ramamurthy ceased to be Director.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Acculi Labs Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acculi Labs Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acculi Labs Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Acculi Labs Private Limited
Acculi Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAPCA6376B1ZE | Karnataka | Active | 09 May 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acculi Labs Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Acculi Labs Private Limited
Frequently Asked Questions about Acculi Labs Private Limited
Acculi Labs is an active private limited company based in Bangalore, Karnataka, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 30 May 2017 (9+ years old) and is registered under CIN U72900KA2017PTC103431.
Acculi Labs reported revenue of ₹15.75 Lakh for FY 2022 (up 29% YoY).
Acculi Labs has 3 current directors:
- Rupam Das - Director
- Akbar - Director
- Moumita Das - Director
Acculi Labs reported a net loss of ₹46.44 Lakh (net margin -294.8%) and EBITDA of -₹41.59 Lakh (EBITDA margin -264%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Acculi Labs is 13% over three years. In the latest year (FY 2022) revenue rose 29%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Acculi Labs is 29AAPCA6376B1ZE, registered in Karnataka.
The CIN (Corporate Identification Number) of Acculi Labs is U72900KA2017PTC103431. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acculi Labs was incorporated on 30 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.
Acculi Labs has 14 deals on record (11 funding rounds, 3 secondary share transfers), with disclosed funding of ₹14.65 Cr; the latest was in August 2024.
The peers of Acculi Labs by revenue are Neuberg Anand Reference Laboratory Private Limited, Nextgen Lifecare Private Limited, Varrow Health Private Limited, Circee Health Private Limited, Lifequest Diagnostic Centre Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Amit Mogra ceased to be Additional Director on 29 Jul 2022. Amit Mogra was appointed as Additional Director on 17 May 2022. Manjula Jeevanna ceased to be Additional Director on 30 Nov 2021. Acculi Labs has 13 board changes on record in total.